Any person, 4 weeks to 15 years, presenting with barking cough and/or stridor.
This protocol is intended to be used by registered and enrolled nurses within their scope of practice and as outlined in The Use of Emergency Care Assessment and Treatment Protocols (PD2024_011). Sections marked triangle or diamond indicate the need for additional prerequisite education prior to use. Check the medication table for dose adjustments and links to relevant reference texts.
- Occurs generally between the ages of 6 months and 6 years. Consider alternative causes outside these age ranges.
- Uncommon in less than 6 months and rare in less than 3 months.
- Alternative diagnoses include: bacterial tracheitis, inhaled foreign body, anaphylaxis, epiglottis, peritonsillar abscess and retropharyngeal abscess.
History prompts, signs and symptoms
These are not exhaustive lists. Maintain an open mind and be aware of cognitive bias.
History prompts
- Presenting complaint
- Onset of symptoms
- Pre-hospital treatment
- Past admissions
- Medical and surgical history, including laryngomalacia or tracheomalacia
- Current medications
- Known allergies
- Immunisation status
- Current weight
Signs and symptoms
- Stridor
- Hoarse voice
- Increased work of breathing
- Barking cough
- Pallor
- Fever
Red flags
Recognise: identify indicators of actual or potential clinical severity and risk of deterioration.
Respond: carefully consider alternative ECAT protocol. Escalate as per clinical reasoning and local CERS protocol, and continue treatment.
Historical
- History of severe croup
- Known structural airway abnormality
- Child less than 3 months old
Clinical
- Altered level of consciousness
- Hypoxia
- Marked accessory muscle use
- Severe respiratory distress
- Lethargy, fatigue or floppiness
- Drooling and/or difficulty swallowing
- High fever
- Unwell
- Stiff neck
Remember child or adolescent at risk: patient or carer concern, suspected non-accidental injury or neglect, multiple comorbidities or unplanned return.
Clinical assessment and specified intervention (A to G)
If the patient has any Yellow or Red Zone observations or additional criteria (as per the relevant NSW Standard Emergency Observation Chart), refer and escalate as per local CERS protocol and continue treatment.
Position
Assessment | Intervention |
---|---|
General appearance/first impressions | Allow the patient to adopt their own position of comfort Do not disturb unnecessarily Exhaustion and/or distress is a sign of serious illness Treat as per severity score |
Airway
Assessment | Intervention |
---|---|
Severe or life-threatening croup
| Immediately escalate as per local CERS protocol Minimise distress to the child Give nebulised adrenaline (epinephrine) 5 mg (equivalent to 5 mL or 5 ampoules of 1:1000) undiluted, with 8–10 L of oxygen via nebuliser. Repeat nebulised adrenaline dose every 15 minutes until improvement or airway support obtained And give one of:
|
Mild–moderate croup
| Minimise distress to the child If stable with mild–moderate symptoms, complete a full A to G assessment before further management Give corticosteroid following A to G assessment, see specific treatment section |
Breathing
Assessment | Intervention |
---|---|
Respiratory rate and work of breathing Oxygen saturation (SpO2) | Do not disturb the child unnecessarily Visually inspect work of breathing using a hands-off approach SpO2 monitoring is only required in life-threatening croup |
Circulation
Assessment | Intervention |
---|---|
Perfusion (capillary refill, skin warmth and colour) Heart rate | Assess circulation Note: children who have required adrenaline as first-line management may have pallor due to vasoconstriction |
Disability
Assessment | Intervention |
---|---|
AVPU | If AVPU shows reduced level of consciousness, continue to assess GCS, pupillary response and limb strength |
GCS, pupillary response and limb strength | Obtain baseline and repeat assessment as clinically indicated |
Pain | Assess pain. If indicated, give early analgesia as per analgesia section then resume A to G assessment |
Reassess. If minimal or poor response:
- repeat nebulised adrenaline (epinephrine) dose
- consider an alternative diagnosis
- escalate as per local CERS protocol.
Exposure
Assessment | Intervention |
---|---|
Temperature | Measure temperature |
Head-to-toe inspection, including posterior surfaces | Check and document any abnormalities Do not disturb child unnecessarily |
Fluids
Assessment | Intervention |
---|---|
Hydration status | Assess fluids, in and out. Document on fluid balance chart. Include gastrointestinal losses |
Repeat and document assessment and observations to monitor responses to interventions, identify developing trends and clinical deterioration. Escalate care as required according to the local CERS protocol.
Focused assessment
Complete a respiratory focused assessment.
Precautions and notes
- The loudness of stridor is a poor indicator of the severity of obstruction. Soft stridor in the context of worsening clinical indicators may be a sign of imminent airway obstruction.
- Less severe cases can be managed with corticosteroids alone.
- Oxygen saturations may be near normal in croup, hypoxia is a late sign of deterioration.
- Humidified air has not been proven to change the severity of croup.
- Supplemental oxygen is not usually required.
- Minimise handling, and reduce distress, to avoid worsening symptoms.
- Alternative diagnoses include, bacterial tracheitis, inhaled foreign body, anaphylaxis, epiglottis, peritonsillar abscess or retropharyngeal abscess.
Interventions and diagnostics
Specific treatment
Mild–moderate croup
Give dexamethasone 0.15 mg/kg orally once only, maximum dose 12 mg
or give prednisolone 1 mg/kg orally once only, maximum dose 50 mg
or if oral corticosteroid is not tolerated, give nebulised budesonide 2 mg once only
Analgesia
If pain score 1–6 (mild–moderate):
Give paracetamol 15 mg/kg orally once only, maximum dose 1000 mg
and/or ibuprofen, if 3 months and over, 10 mg/kg orally once only, maximum dose 400 mg
If severe pain present, give analgesia and escalate as per local CERS protocol.
Consider non-pharmacological pain relief (appendix).
Nausea and/or vomiting
If nausea and/or vomiting is present and over 6 months give:
ondansetron:
- 8–15 kg: 2 mg, orally once only
- 15–30 kg: 4 mg, orally once only
- Over 30 kg: 8 mg, orally once only.
Radiology
Not usually indicated. If there is concern for urgent radiology, escalate care as per local CERS protocol.
Pathology
Not usually indicated. If there is concern for urgent pathology, escalate care as per local CERS protocol.
Medications
The patient’s weight is mandatory for calculating fluid and medication doses.
The Broselow Tape or APLS weight table (appendix) can be used only in circumstances where the patient cannot be weighed.
The shaded sections in this protocol are only to be used by registered nurses who have completed the required education.
Drag the table right to view more columns or turn your phone to landscape
Drug | Dose | Route | Frequency |
---|---|---|---|
5 mg | Inhalation via nebuliser | Severe or life-threatening croup: every 15 minutes (until improvement) | |
2 mg | Inhalation via nebuliser | If unable to tolerate oral dexamethasone or prednisolone Once only | |
0.6 mg/kg Maximum dose 12 mg | Oral/IV/IM | Severe or life-threatening croup Once only | |
0.15 mg/kg Maximum dose 12 mg | Oral | Mild–moderate croup Once only | |
Ibuprofen H, R | 3 months and over: Maximum dose 400 mg | Oral | Pain score 1–10 Once only |
Over 6 months and 8–15 kg: 15–30 kg: Over 30 kg: | Oral | Once only | |
0.25–15 L/min, device dependent | Inhalation | Continuous | |
15 mg/kg Maximum dose 1000 mg | Oral | Pain score 1–10 Once only | |
1 mg/kg Maximum dose 50 mg | Oral | Once only |
Medications with contraindications or requiring dose adjustment are marked:
- H for patients with known hepatic impairment
- R for patients with known renal impairment.
Escalate to medical or nurse practitioner.
References
- Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev. 2023 Jan 10;1(1):Cd001955. DOI: 10.1002/14651858.CD001955.pub5
- The Royal Children's Hospital Melbourne. Oxygen delivery. Melbourne: Victoria Health; 2017 [cited 23 Feb 2023]. Available from: https://www.rch.org.au/rchcpg/hospital_clinical_guideline_index/Oxygen_delivery/
- Bjornson C, Johnson D. Croup. USA: BMJ Best Practice; 2019 [cited 24 Feb 2023]. Available from: https://bestpractice.bmj.com/topics/en-gb/681#:~:text=Croup%2C%20also%20known%20as%20laryngotracheobronchitis,voice%20hoarseness%2C%20and%20respiratory%20distress.
- Bjornson C, Russell K, Vandermeer B, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev. 2013 (10). Available from: https://doi.org//10.1002/14651858.CD006619.pub3 DOI: 10.1002/14651858.CD006619.pub3
- Children's Health Queensland Hospital and Health Service. Queensland paediatric guideline: Croup - Emergency management in children. Queensland: Queensland Health; 2019 [cited 24 Feb 2023]. Available from: https://www.childrens.health.qld.gov.au/wp-content/uploads/PDF/guidelines/CHQ-GDL-60004-Croup.pdf
- Kawaguchi A, Joffe A. Evidence for clinicians: Nebulized epinephrine for croup in children. Paediatr Child Health. 2015 Jan-Feb;20(1):19-20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333749/ DOI: 10.1093/pch/20.1.19
- MIMS Australia. Clinical Resources. Australia: MIMS Australia Pty Ltd; 2022 [cited 2 Feb 2023]. Available from: https://www.mimsonline.com.au.acs.hcn.com.au/Search/Search.aspx
- Australian Medicines Handbook. Adelaide: AMH; c2023 [cited 28 Feb 2023]. Available from: https://amhonline.amh.net.au.acs.hcn.com.au/
- Australian Medicines Handbook Children’s Dosing Companion. Adelaide: AMH; c2023 [cited 03 May 2023]. Available from: https://childrens.amh.net.au.acs.hcn.com.au/
- Ortiz-Alvarez O. Acute management of croup in the emergency department. Paediatr Child Health. 2017;22(3):166-9. DOI: 10.1093/pch/pxx019
- Smith DK, McDermott AJ, Sullivan JF. Croup: Diagnosis and Management. Am Fam Physician. 2018 May 1;97(9):575-80.
- The Royal Children's Hospital Melbourne. Clinical practice guidelines: Croup (Laryngotracheobronchitis). Melbourne: Victoria Health; 2020 [cited 24 Feb 2023]. Available from: https://www.rch.org.au/clinicalguide/guideline_index/Croup_Laryngotracheobronchitis/
- The Sydney Children's Hospital Network. Meds 4 Kids Dosing Guide. Australia: NSW Health; 2023 [cited 23 Feb 2023]. Available from: https://webapps.schn.health.nsw.gov.au/meds4kids/
- Theapeutic Guidelines. Croup. Australia: Therapeutic Guidelines Limited; 2020 [cited 2 March 2023]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?etgAccess=true&guidelinePage=Respiratory&topicfile=croup&guidelinename=Respiratory§ionId=toc_d1e47#toc_d1e47
- Therapeutic Guidelines. Management of mild to moderate croup. Australia: Therapeutic Guidelines Limited; 2020 [cited 22 March 2023]. Available from: https://tgldcdp.tg.org.au.acs.hcn.com.au/viewTopic?etgAccess=true&guidelinePage=Respiratory&topicfile=croup&guidelinename=Respiratory§ionId=toc_d1e190#toc_d1e190
- Woods C. Management of croup. UpToDate: Wolters Kluwer; 2023 [cited 02 March 2023]. Available from: https://www.uptodate.com.acs.hcn.com.au/contents/management-of-croup?search=management%20of%20croup&source=search_result&selectedTitle=1~73&usage_type=default&display_rank=1
- Wright M, Bush A. Assessment and management of viral croup in children. Prescriber. 2016;27(8):32-7. DOI: https://doi.org/10.1002/psb.1490
Evidence informed |
Information was drawn from evidence-based guidelines and a review of latest available research. For more information, see the development process. |
Collaboration |
This protocol was developed by the ECAT Working Group, led by the Agency for Clinical Innovation. The group involved expert medical, nursing and allied health representatives from local health districts across NSW. Consensus was reached on all recommendations included within this protocol. |
Currency | Due for review: Jan 2026. Based on a regular review cycle. |
Feedback | Email ACI-ECIs@health.nsw.gov.au |
Accessed from the Emergency Care Institute website at https://aci.health.nsw.gov.au/ecat/paediatric/croup-like-illness